USPTO serial 79233972
XIRXON
Reviewed by CopyMark Law Group
Reg. 6835695Status 404
- Filing date
- Status date
- Registration date
- Sep 6, 2022
- Examiner
- RHIM,ANDREW
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with XIRXON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jan 5, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 6, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 6, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 21, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 21, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 1, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 1, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 1, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 17, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2022 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Feb 3, 2022 | CRTP | REG. CANCELLED - RESTORED TO PENDENCY | — |
| Jan 24, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 20, 2022 | RCII | REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED | — |
| Jul 26, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 12, 2019 | FINP | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 14, 2019 | IRRH | IRREGULARITY FROM IB EXAMINED BY MPU | — |
| Mar 11, 2019 | IRFI | IRREGULARITY ON FINAL DECISION RECEIVED FROM IB | — |
| Feb 22, 2019 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 22, 2019 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 14, 2019 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| Jan 23, 2019 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Jan 16, 2019 | CHPN | POST PUBLICATION AMENDMENT – NOT ENTERED | — |
| Jan 15, 2019 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 15, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 21, 2018 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Dec 20, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Dec 19, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 9, 2018 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Aug 30, 2018 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jul 31, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 11, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 28, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 26, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2018 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jun 7, 2018 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |